D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics and Molecular Biology D-index 49 Citations 8,485 95 World Ranking 3847 National Ranking 1817

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Pulivarthi H. Rao mainly investigates Molecular biology, Cancer research, Comparative genomic hybridization, Genetics and Gene duplication. His biological study spans a wide range of topics, including Metaphase, Cell biology, CD19 and Chromosomal translocation. His study looks at the relationship between Chromosomal translocation and topics such as Gene rearrangement, which overlap with Breakpoint.

His Cancer research research is multidisciplinary, relying on both Oncogene, Pathology, Gene mapping, Interferon regulatory factors and Multiple myeloma. He has researched Comparative genomic hybridization in several fields, including Tumor progression and Cytogenetics. His Gene duplication research integrates issues from Gene dosage, Fluorescence in situ hybridization, Amplicon and Cervical cancer.

His most cited work include:

  • Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification (338 citations)
  • Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. (302 citations)
  • Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma (300 citations)

What are the main themes of his work throughout his whole career to date?

Pulivarthi H. Rao focuses on Cancer research, Molecular biology, Genetics, Comparative genomic hybridization and Pathology. His Cancer research research includes elements of Carcinogenesis, Cancer, Regulation of gene expression and Oncogene. His Molecular biology course of study focuses on Fluorescence in situ hybridization and Genetic marker.

His work deals with themes such as Gene expression profiling, Internal medicine, Thyroid, Cytogenetics and Gene duplication, which intersect with Comparative genomic hybridization. His work carried out in the field of Gene duplication brings together such families of science as Gene dosage and Amplicon. His study in Pathology is interdisciplinary in nature, drawing from both Karyotype and Adenocarcinoma.

He most often published in these fields:

  • Cancer research (35.81%)
  • Molecular biology (29.05%)
  • Genetics (27.03%)

What were the highlights of his more recent work (between 2013-2020)?

  • Cancer research (35.81%)
  • Osteosarcoma (7.43%)
  • Pathology (25.68%)

In recent papers he was focusing on the following fields of study:

His main research concerns Cancer research, Osteosarcoma, Pathology, Cell culture and Gene. The various areas that Pulivarthi H. Rao examines in his Cancer research study include Carcinogenesis, Cancer, Breast cancer, Oncogene and Immunology. His Pathology study combines topics from a wide range of disciplines, such as Isochromosome, Karyotype, Chromosome abnormality, Phenotype and Cytogenetics.

In his research, Salivary duct carcinoma, Molecular biology and Androgen receptor is intimately related to PTEN, which falls under the overarching field of Telomerase reverse transcriptase. Pulivarthi H. Rao undertakes interdisciplinary study in the fields of Molecular biology and PVT1 through his research. As a part of the same scientific study, Pulivarthi H. Rao usually deals with the Chromosomal translocation, concentrating on Parotid gland and frequently concerns with Chromosome.

Between 2013 and 2020, his most popular works were:

  • TP53 loss creates therapeutic vulnerability in colorectal cancer (136 citations)
  • Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations (96 citations)
  • PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium (93 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His primary scientific interests are in Cancer research, Osteosarcoma, Immunology, Carcinogenesis and Colorectal cancer. His research in Cancer research intersects with topics in Cancer, Cell cycle, Anaphase, Loss of heterozygosity and Tumor suppressor gene. His Cancer study is concerned with the field of Genetics as a whole.

His Osteosarcoma research is multidisciplinary, incorporating elements of Insulin-like growth factor 1 receptor, Growth factor, Penetrance and Targeted therapy. He combines subjects such as Malignancy, Transcriptome, Oncogene, RBPJ and Sarcoma with his study of Carcinogenesis. Within one scientific family, Pulivarthi H. Rao focuses on topics pertaining to Bioinformatics under Colorectal cancer, and may sometimes address concerns connected to Gene, Cell growth and Gene dosage.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification

Davide Ruggero;Silvia Grisendi;Francesco Piazza;Eduardo Rego.
Science (2003)

451 Citations

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.

Maria Barna;Aya Pusic;Ornella Zollo;Maria Costa.
Nature (2008)

400 Citations

Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

Shinsuke Iida;Pulivarthi H. Rao;Marion Butler;Paolo Corradini.
Nature Genetics (1997)

367 Citations

Chromosomal and gene amplification in diffuse large B-cell lymphoma

Pulivarthi H. Rao;Jane Houldsworth;Katerina Dyomina;Nasser Z. Parsa.
Blood (1998)

366 Citations

Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance

Yoshitsugu Mitani;Jie Li;Pulivarthi H. Rao;Yi Jue Zhao.
Clinical Cancer Research (2010)

297 Citations

Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.

Joseph C. Presti;P. H. Rao;Q. Chen;Victor E. Reuter.
Cancer Research (1991)

296 Citations

REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma

Jane Houldsworth;Susan Mathew;Pulivarthi H. Rao;Katerina Dyomina.
Blood (1996)

282 Citations

IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy

Georgia Hatzivassiliou;Ira Miller;Jun Takizawa;Nallasivam Palanisamy.
Immunity (2001)

264 Citations

p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas

Bhuvanesh Singh;Pabbathi G. Reddy;Andy Goberdhan;Christine Walsh.
Genes & Development (2002)

254 Citations

The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability

Michael Overholtzer;Michael Overholtzer;Pulivarthi H. Rao;Reyna Favis;Xin Yan Lu.
Proceedings of the National Academy of Sciences of the United States of America (2003)

230 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pulivarthi H. Rao

Laurence J.N. Cooper

Laurence J.N. Cooper

The University of Texas MD Anderson Cancer Center

Publications: 42

Jeremy A. Squire

Jeremy A. Squire

Universidade de São Paulo

Publications: 37

Bhuvanesh Singh

Bhuvanesh Singh

Memorial Sloan Kettering Cancer Center

Publications: 35

Riccardo Dalla-Favera

Riccardo Dalla-Favera

Columbia University

Publications: 34

Ronald Ghossein

Ronald Ghossein

Memorial Sloan Kettering Cancer Center

Publications: 32

R. S. K. Chaganti

R. S. K. Chaganti

Memorial Sloan Kettering Cancer Center

Publications: 30

Reiner Siebert

Reiner Siebert

University of Ulm

Publications: 30

Davide Ruggero

Davide Ruggero

University of California, San Francisco

Publications: 28

Dean A. Lee

Dean A. Lee

Nationwide Children's Hospital

Publications: 26

Vundavalli V. Murty

Vundavalli V. Murty

Columbia University Medical Center

Publications: 25

Sakari Knuutila

Sakari Knuutila

University of Helsinki

Publications: 24

Adel K. El-Naggar

Adel K. El-Naggar

The University of Texas MD Anderson Cancer Center

Publications: 24

Max D. Cooper

Max D. Cooper

Emory University

Publications: 22

Tej K. Pandita

Tej K. Pandita

Houston Methodist

Publications: 20

Richard Gorlick

Richard Gorlick

The University of Texas MD Anderson Cancer Center

Publications: 19

Göran Stenman

Göran Stenman

University of Gothenburg

Publications: 19

Something went wrong. Please try again later.